Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses

PloS One
Miguel Ángel Muñoz-AlíaStephen J Russell

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive, lethal complication of measles caused by particular mutants of measles virus (MeV) that persist in the brain despite high levels of neutralizing antibodies. We addressed the hypothesis that antigenic drift is involved in the pathogenetic mechanism of SSPE by analyzing antigenic alterations in the MeV envelope hemagglutinin protein (MeV-H) found in patients with SSPE in relation to major circulating MeV genotypes. To this aim, we obtained cDNA for the MeV-H gene from tissue taken at brain autopsy from 3 deceased persons with SSPE who had short (3-4 months, SMa79), average (3.5 years, SMa84), and long (18 years, SMa94) disease courses. Recombinant MeVs with a substituted MeV-H gene were generated by a reverse genetic system. Virus neutralization assays with a panel of anti-MeV-H murine monoclonal antibodies (mAbs) or vaccine-immunized mouse anti-MeV-H polyclonal sera were performed to determine the antigenic relatedness. Functional and receptor-binding analysis of the SSPE MeV-H showed activity in a SLAM/nectin-4-dependent manner. Similar to our panel of wild-type viruses, our SSPE viruses showed an altered antigenic profile. Genotypes A, G3, and F (SSPE case SMa79) wer...Continue Reading

References

May 1, 1973·The Journal of Infectious Diseases·F E Payne, J V Baublis
Jan 1, 1983·Progress in Brain Research·M J Carter, V Ter Meulen
May 1, 1995·The Journal of General Virology·B K RimaR Fernandez-Muñoz
Jan 1, 1997·The Journal of General Virology·B K RimaR Fernandez-Muñoz
Apr 10, 1999·Journal of Virology·C L ParksS A Udem
Sep 6, 2000·Nature·H TatsuoY Yanagi
Jun 20, 2001·Journal of Virology·V von MesslingR Cattaneo
Sep 20, 2001·The Journal of General Virology·C H WoelkD W Brown
May 25, 2002·The Journal of General Virology·Christopher H WoelkEdward C Holmes
Aug 6, 2002·Journal of Neurovirology·L JinE Miller
Mar 3, 2004·Nature Biotechnology·Takafumi NakamuraStephen J Russell
Apr 27, 2004·Microbiology and Immunology·Hiroshi IshidaHisashi Ogura
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Pei ZhangStephen M Feinstone
Sep 7, 2007·Journal of Virology·Kosei HasegawaKah-Whye Peng
Feb 23, 2008·The Journal of Biological Chemistry·Chanakha K NavaratnarajahRoberto Cattaneo
May 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Wilfred NdifonSimon A Levin
Oct 29, 2009·Biochemical and Biophysical Research Communications·Lilin ZhongPei Zhang
Sep 9, 2011·PLoS Pathogens·Ryan S NoyceChristopher D Richardson
Nov 4, 2011·Nature·Michael D MühlebachRoberto Cattaneo
Feb 10, 2012·FEMS Microbiology Reviews·Diane E GriffinChien-Hsiung Pan
Jul 5, 2012·Journal of Virology·Watanyoo PratakpiriyaRyoji Yamaguchi
Dec 6, 2012·Nature Communications·Yuta ShiroganeYusuke Yanagi

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
electrophoresis
glycosylation
flow
protein assay
ELISA

Software Mentioned

Elements
NIS
NetNGlyc
GraphPad Prism

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.